搜索





搜索





市场行情
/
股票
/
imvt
/

Immunovant Inc

IMVT

添加自选

38.620USD

-0.860-2.18%

收盘 07-31 16:00（美东）报价延迟15分钟

7.88B总市值

亏损市盈率 TTM

Immunovant Inc

38.620

-0.860-2.18%

概览

财务

分析

公司

财务摘要利润表资产负债表现金流量表

IMVT 利润表

您可以在这里找到Immunovant Inc的年度或季度收入报告，以深入了解Immunovant Inc的运营、管理效率和表现。

单季报

单季报+年报

单季报

年报

YOY

隐藏空白行

FY2026Q4

FY2026Q3

FY2026Q2

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q4

FY2020Q3

FY2020Q2

FY2020Q1

营业费用

5.95%120.60M

0.05%114.36M

13.84%131.76M

34.94%127.22M

40.73%113.83M

85.70%114.30M

87.29%115.74M

42.90%94.28M

25.86%80.88M

13.93%61.55M

24.56%61.80M

63.41%65.98M

36.06%64.26M

30.91%54.03M

31.78%49.61M

35.10%40.38M

63.32%47.23M

30.44%41.27M

79.51%37.65M

12.41%29.89M

41.18%28.92M

7437.69%31.64M

22613.39%20.97M

5907900.00%26.59M

--20.48M

--419.76K

--92.34K

--450.00

研发费用

10.34%103.33M

4.66%98.92M

17.45%114.25M

34.09%101.20M

41.78%93.65M

95.54%94.52M

102.82%97.27M

49.23%75.47M

27.43%66.06M

14.40%48.34M

27.08%47.96M

77.90%50.58M

62.06%51.84M

41.99%42.25M

76.67%37.74M

51.99%28.43M

71.83%31.99M

41.08%29.76M

78.37%21.36M

10.54%18.70M

31.39%18.61M

325.82%21.09M

--11.98M

--16.92M

--14.17M

--4.95M

----

折旧摊销及损耗

-11.93%96.00K

2.02%101.00K

17.98%105.00K

33.75%107.00K

70.31%109.00K

70.69%99.00K

58.93%89.00K

50.94%80.00K

18.52%64.00K

18.37%58.00K

21.74%56.00K

20.45%53.00K

38.46%54.00K

48.48%49.00K

64.29%46.00K

69.23%44.00K

77.27%39.00K

73.68%33.00K

100.00%28.00K

160.00%26.00K

266.67%22.00K

26.67%19.00K

--14.00K

--10.00K

--6.00K

--15.00K

----

其他营业费用

----

--395.16K

--67.74K

--450.00

营业利润

-5.95%-120.60M

-0.05%-114.36M

-13.84%-131.76M

-34.94%-127.22M

-40.73%-113.83M

-85.70%-114.30M

-87.29%-115.74M

-42.90%-94.28M

-25.86%-80.88M

-13.93%-61.55M

-24.56%-61.80M

-63.41%-65.98M

-36.06%-64.26M

-30.91%-54.03M

-31.78%-49.61M

-35.10%-40.38M

-63.32%-47.23M

-30.44%-41.27M

-79.51%-37.65M

-12.41%-29.89M

-41.18%-28.92M

-7437.69%-31.64M

-22613.39%-20.97M

-5907900.00%-26.59M

---20.48M

---419.76K

---92.34K

---450.00

净非营业利息收入（费用）

利息收入

16.96%8.06M

16.19%5.33M

-7.72%5.60M

-11.74%6.34M

-17.79%6.89M

-48.62%4.59M

70.02%6.07M

76.63%7.18M

140.78%8.38M

203.43%8.93M

209.53%3.57M

--4.07M

--3.48M

--2.94M

--1.15M

----

--683.14K

--341.56K

----

利息费用

----

--0.00

-100.00%0.00

--0.00

----

--0.00

--376.00K

----

特殊收入（费用）

---38.95M

----

--0.00

100.00%0.00

--0.00

100.00%0.00

--0.00

---12.50M

--0.00

---10.00M

----

其他非经营性收入（费用）

-25.49%798.00K

95.71%-54.00K

-60.25%250.00K

4139.29%1.19M

141.40%1.07M

-214.99%-1.26M

3045.00%629.00K

-93.97%28.00K

-826.69%-2.59M

162.27%1.09M

-97.48%20.00K

31.07%464.00K

709.09%356.00K

-1441.23%-1.76M

1044.05%793.00K

156.55%354.00K

-93.53%44.00K

77.34%-114.00K

-137.33%-84.00K

-745.95%-626.00K

635.43%680.00K

-327.60%-503.00K

--225.00K

---74.00K

---127.00K

--221.00K

----

税前利润

-42.35%-150.70M

1.70%-109.08M

-15.47%-125.91M

-37.47%-119.70M

-40.99%-105.87M

-115.37%-110.97M

-87.33%-109.04M

-17.75%-87.07M

-24.27%-75.09M

18.00%-51.53M

-22.11%-58.21M

-84.77%-73.95M

-28.06%-60.42M

-51.84%-62.84M

-26.32%-47.67M

-31.16%-40.02M

-67.10%-47.18M

-28.75%-41.38M

-81.86%-37.73M

-14.45%-30.51M

-37.01%-28.24M

-12303.90%-32.14M

-8425.71%-20.75M

-5924344.44%-26.66M

---20.61M

--263.38K

--249.22K

---450.00

所得税

-587.82%-2.84M

921.05%1.55M

661.54%594.00K

1085.71%913.00K

151.29%583.00K

240.74%152.00K

-82.82%78.00K

800.00%77.00K

123.41%232.00K

-127.91%-108.00K

73.95%454.00K

-103.13%-11.00K

-8158.33%-991.00K

--387.00K

941.94%261.00K

958.54%352.00K

84.81%-12.00K

100.00%0.00

-177.50%-31.00K

-185.42%-41.00K

-33.90%-79.00K

-365.38%-367.00K

-39.82%40.00K

--48.00K

---59.00K

--138.29K

--66.47K

----

除税后利润

-38.90%-147.86M

0.44%-110.64M

-15.93%-126.50M

-38.40%-120.61M

-41.33%-106.45M

-116.11%-111.12M

-86.01%-109.12M

-17.87%-87.15M

-26.73%-75.32M

18.68%-51.42M

-22.40%-58.66M

-83.13%-73.94M

-25.99%-59.43M

-52.78%-63.23M

-27.12%-47.93M

-32.50%-40.37M

-67.52%-47.17M

-30.24%-41.38M

-81.36%-37.70M

-14.09%-30.47M

-37.02%-28.16M

-25502.51%-31.78M

-11475.71%-20.79M

-5935011.11%-26.71M

---20.55M

--125.09K

--182.75K

---450.00

持续经营利润

-38.90%-147.86M

0.44%-110.64M

-15.93%-126.50M

-38.40%-120.61M

-41.33%-106.45M

-116.11%-111.12M

-86.01%-109.12M

-17.87%-87.15M

-26.73%-75.32M

18.68%-51.42M

-22.40%-58.66M

-83.13%-73.94M

-25.99%-59.43M

-52.78%-63.23M

-27.12%-47.93M

-32.50%-40.37M

-67.52%-47.17M

-30.24%-41.38M

-81.36%-37.70M

-14.09%-30.47M

-37.02%-28.16M

-25502.51%-31.78M

-11475.71%-20.79M

-5935011.11%-26.71M

---20.55M

--125.09K

--182.75K

---450.00

归属于母公司的净利润

-38.90%-147.86M

0.44%-110.64M

-15.93%-126.50M

-38.40%-120.61M

-41.33%-106.45M

-116.11%-111.12M

-86.01%-109.12M

-17.87%-87.15M

-26.73%-75.32M

18.68%-51.42M

-22.40%-58.66M

-83.13%-73.94M

-25.99%-59.43M

-52.78%-63.23M

-27.12%-47.93M

-32.50%-40.37M

-67.52%-47.17M

-30.24%-41.38M

-81.36%-37.70M

-14.09%-30.47M

-37.02%-28.16M

-25502.51%-31.78M

-11475.71%-20.79M

-5935011.11%-26.71M

---20.55M

--125.09K

--182.75K

---450.00

归属于普通股东的净利润

-38.90%-147.86M

0.44%-110.64M

-15.93%-126.50M

-38.40%-120.61M

-41.33%-106.45M

-116.11%-111.12M

-86.01%-109.12M

-17.87%-87.15M

-26.73%-75.32M

18.68%-51.42M

-22.40%-58.66M

-83.13%-73.94M

-25.99%-59.43M

-52.78%-63.23M

-27.12%-47.93M

-32.50%-40.37M

-67.52%-47.17M

-30.24%-41.38M

-81.36%-37.70M

-14.09%-30.47M

-37.02%-28.16M

-25502.51%-31.78M

-11475.71%-20.79M

-5935011.11%-26.71M

---20.55M

--125.09K

--182.75K

---450.00

基本每股收益

-13.75%-0.73

19.41%-0.61

2.21%-0.73

-18.32%-0.71

-23.57%-0.64

-112.58%-0.76

-66.57%-0.74

-5.30%-0.60

-13.36%-0.52

27.65%-0.36

-8.79%-0.45

-63.56%-0.57

-12.52%-0.46

-36.68%-0.49

-18.95%-0.41

-11.74%-0.35

-40.76%-0.41

-10.87%-0.36

-40.25%-0.35

17.80%-0.31

23.53%-0.29

-3830.00%-0.32

-2039.02%-0.25

-942725.00%-0.38

---0.38

--0.01

--0.00

稀释每股收益

-13.75%-0.73

19.41%-0.61

2.21%-0.73

-18.32%-0.71

-23.57%-0.64

-112.58%-0.76

-66.57%-0.74

-5.30%-0.60

-13.36%-0.52

27.65%-0.36

-8.79%-0.45

-63.56%-0.57

-12.52%-0.46

-36.68%-0.49

-18.95%-0.41

-11.74%-0.35

-40.76%-0.41

-10.87%-0.36

-40.25%-0.35

17.80%-0.31

23.53%-0.29

-3830.00%-0.32

-2039.02%-0.25

-942725.00%-0.38

---0.38

--0.01

--0.00

每股派息

--0.00

货币单位

--USD

审计意见

----

常见问题

如何在 TradingKey 上查看 Immunovant Inc 的利润表？



先看总营收，再依次查看营收成本、毛利润、营业费用、营业利润、税前利润、净利润和每股收益（EPS）。营收反映公司的业务规模，而各项利润和利润率则体现公司能否有效地将营收转化为盈利。

季度利润表和年度利润表有什么区别？



季度利润表反映公司在一个为期三个月的财务季度内的经营表现，年度利润表则汇总整个财年的业绩。季度数据适合用于观察近期发展势头和季节性变化，年度数据则更适合评估长期增长、盈利能力和业务周期。

利润表页面中的同比是什么意思？



同比是指将某项财务指标与上年同期进行比较，例如将本季度营收与去年同一季度的营收进行对比。同比数据有助于投资者观察增长趋势，同时减少正常季节性变化对分析的影响。

分析 IMVT 股票时，哪些利润表指标最重要？



重要的指标包括营收增长、毛利润、毛利率、营业利润、营业利润率、净利润、每股收益、研发费用、销售及管理费用以及所得税费用。投资者通常会综合分析这些指标，以判断公司是否正在增长、有效控制成本并提升盈利能力。

Immunovant Inc 全年的净利润是多少？



Immunovant Inc 2025 财年净利润为 -505.61M。

Immunovant Inc 上一季度的净利润是多少？



Immunovant Inc 最近一个季度的净利润为 -147.86M。

Immunovant Inc 年度营业利润是多少？



Immunovant Inc 2025 财年的营业利润为 -438.15M。

每股收益与利润表有什么关系？



每股收益（EPS）通常以净利润除以流通在外的股份数量计算，用于衡量公司平均每股创造的利润。分析 EPS 时，还应结合股本变化、利润率、现金流和估值指标进行综合判断。